Abstract
Introduction
Myotonic disorders are a group of diseases affecting the muscle, in different ways. Myotonic dystrophy type 1 (DM1) is related to (CTG)n expansion in the 3-untranslated region of the dystrophia myotonica protein kinase (DMPK) gene and is the most frequent and disabling form, causing muscular, visibility, respiratory, and cardiac impairment. Non-dystrophic myotonias (NDMs) affect the skeletal muscle alone. In particular, mutations in the chloride channel (CLCN1) gene cause myotonia congenita (MC), which can have autosomal dominant or recessive inheritance.
Case report
We describe a patient with a family history of asymptomatic or paucisymptomatic myotonia, who presented handgrip myotonia which sharply reduced after mexiletine administration. Molecular analysis showed both a paternally inherited DMPK expansion and a maternally inherited CLCN1 mutation.
Conclusions
Only one other similar case was reported so far; however, the segregation of the two mutations and the characteristics of the muscle were not studied. Since our patient lacked the classical phenotypical and muscle histopathological characteristics of DM1 and showed mild splicing alterations despite a pathogenic DMPK expansion and the nuclear accumulation of toxic RNA, we may speculate that the co-occurrence of a CLCN1 mutation could have attenuated the severity of DM1 phenotype.
This is a preview of subscription content, log in via an institution to check access.
References
Tan SV, Z’Graggen WJ, Boërio D, Rayan DR et al (2014) Chloride channels in myotonia congenita assessed by velocity recovery cycles. Muscle Nerve 49(6):845–857. https://doi.org/10.1002/mus.24069
Fialho D, Schorge S, Pucovska U et al (2007) Chloride channel myotonia: exon 8 hot-spot for dominant-negative interactions. Brain 130(Pt 12):3265–3274. https://doi.org/10.1093/brain/awm248
Wang K, Preisler SS, Zhang L et al (2019) Structure of the human ClC-1 chloride channel. PLoS Biol 17(4):e3000218. https://doi.org/10.1371/journal.pbio.3000218
Vihola A, Bassez G, Meola G et al (2003) Histopathological differences of myotonic dystrophy type 1 (DM1) and PROMM/DM2. Neurology 60:1854–1857. https://doi.org/10.1212/01.wnl.0000065898.61358.09
Suominen T, Schoser B, Raheem O et al (2008) High frequency of cosegregating CLCN1 mutations among myotonic dystrophy type 2 patients from Finland and Germany. J Neurol 255:1731–1736. https://doi.org/10.1007/s00415-008-0010-z
Kassardjian C, Milone M (2014) Coexistence of DMPK gene expansion and CLCN1 missense mutation in the same patient. Neurogenetics 15:213–214. https://doi.org/10.1007/s10048-014-0402-4
Lueck JD, Lungu C, Mankodi A et al (2007) Chloride channelopathy in myotonic dystrophy resulting from loss of posttranscriptional regulation for CLCN1. Am J Physiol Cell Physiol 292:C1291-1297. https://doi.org/10.1152/ajpcell.00336.2006
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Ethical approval
None.
Conflict of Interest
None.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Highlights
- We describe a myotonic patient harboring both a DMPK expansion and a CLCN1 mutation.
- Both clinical phenotype and bioptic findings were mild.
- CLCN1 mutation could have mitigated DM1 phenotype.
Rights and permissions
About this article
Cite this article
Locci, S., Cardani, R., Brunori, P. et al. Co-occurrence of DMPK expansion and CLCN1 mutation in a patient with myotonia. Neurol Sci 42, 5365–5368 (2021). https://doi.org/10.1007/s10072-021-05538-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10072-021-05538-y